[
  {
    "date": "2023-12-30",
    "symbol": "CRBU",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-40631",
    "entityregistrantname": "Caribou Biosciences, Inc.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "45-3728228",
    "entityaddressaddressline1": "2929 7th Street",
    "entityaddressaddressline2": "Suite 105",
    "entityaddresscityortown": "Berkeley",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 94710,
    "cityareacode": 510,
    "localphonenumber": "982-6030",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "CRBU",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1619856,
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorfirmid": 34,
    "auditorlocation": "San Francisco, California",
    "cashandcashequivalentsatcarryingvalue": 51162000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 277665000,
    "accountsreceivablenetcurrent": 148000,
    "contractwithcustomerassetnetcurrent": 1425000,
    "otherreceivables": 2286000,
    "prepaidexpenseandotherassetscurrent": 6155000,
    "assetscurrent": 338841000,
    "equitymethodinvestments": 7753000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 43577000,
    "propertyplantandequipmentnet": 18270000,
    "operatingleaserightofuseasset": 22182000,
    "otherassetsnoncurrent": 1586000,
    "assets": 432209000,
    "accountspayablecurrent": 3120000,
    "accruedliabilitiescurrent": 21135000,
    "operatingleaseliabilitycurrent": 1200000,
    "contractwithcustomerliabilitycurrent": 2487000,
    "liabilitiescurrent": 28302000,
    "contractwithcustomerliabilitynoncurrent": 3730000,
    "successpaymentliability": 2939000,
    "operatingleaseliabilitynoncurrent": 25908000,
    "deferredincometaxliabilitiesnet": 557000,
    "liabilities": 63808000,
    "commonstockvalue": 8000,
    "additionalpaidincapital": 667648000,
    "accumulatedothercomprehensiveincomelossnetoftax": 30000,
    "retainedearningsaccumulateddeficit": -299285000,
    "stockholdersequity": 368401000,
    "liabilitiesandstockholdersequity": 432209000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 88448948,
    "commonstocksharesoutstanding": 88448948,
    "revenuefromcontractwithcustomerexcludingassessedtax": 2393000,
    "researchanddevelopmentexpense": 112075000,
    "generalandadministrativeexpense": 38461000,
    "operatingexpenses": 150536000,
    "operatingincomeloss": -116059000,
    "equitysecuritiesfvnigainloss": -6000,
    "changeinfairvalueofsuccesspaymentsliability": 1288000,
    "othernonoperatingincome": 15476000,
    "nonoperatingincomeexpense": 14182000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -101877000,
    "incometaxexpensebenefit": 193000,
    "netincomeloss": -102070000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 1548000,
    "comprehensiveincomenetoftax": -100522000,
    "earningspersharebasic": -1.38,
    "earningspersharediluted": -1.38,
    "weightedaveragenumberofsharesoutstandingbasic": 73807597,
    "weightedaveragenumberofdilutedsharesoutstanding": 73807597,
    "sharesoutstanding": 88448948,
    "stockissuedduringperiodsharesemployeebenefitplan": 138454,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 787000,
    "stockissuedduringperiodsharesstockoptionsexercised": 228264,
    "stockissuedduringperiodvaluestockoptionsexercised": 793000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 78596,
    "stockissuedduringperiodsharesnewissues": 22115384,
    "stockissuedduringperiodvaluenewissues": 2000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 13750000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": 1548000,
    "profitloss": -102070000,
    "depreciationdepletionandamortization": 3525000,
    "gainlossondispositionofassets1": 34000,
    "noncashconsiderationforlicensingandcollaborationrevenue": 61000,
    "sharebasedcompensation": 13750000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 4425000,
    "noncashleaseexpense": 2048000,
    "increasedecreaseinaccountsreceivable": -54000,
    "increasedecreaseincontractwithcustomerasset": -822000,
    "increasedecreaseinotherreceivables": 71000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1766000,
    "increasedecreaseinotheroperatingassets": 48000,
    "increasedecreaseinaccountspayable": 1819000,
    "increasedecreaseinaccruedliabilities": 5743000,
    "increasedecreaseincontractwithcustomerliability": -16943000,
    "increasedecreaseinoperatingleaseliability": -637000,
    "increasedecreaseindeferredliabilities": 177000,
    "netcashprovidedbyusedinoperatingactivities": -93291000,
    "proceedsfromsaleandmaturityofavailableforsalesecurities": 338188000,
    "paymentstoacquiremarketablesecurities": 394758000,
    "paymentstoacquirepropertyplantandequipment": 11613000,
    "netcashprovidedbyusedininvestingactivities": -68183000,
    "proceedsfromissuanceoffollowonpublicoffering": 134423000,
    "proceedsfromissuanceofprivateplacement": 17290000,
    "proceedsfromexerciseofstockoptionsandpurchasesofcommonstockunderemployeestockpurchaseplan": 1578000,
    "proceedsfromissuanceofcommonstock": 1007000,
    "netcashprovidedbyusedinfinancingactivities": 154298000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -7176000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 51208000,
    "restrictedcashandcashequivalentsatcarryingvalue": 46000,
    "incometaxespaidnet": 170000,
    "capitalexpendituresincurredbutnotyetpaid": 692000,
    "significantagreementstextblock": "Significant Agreements",
    "commonstocktextblock": "Common Stock",
    "otherincomepolicytextblock": "<div style=\"margin-top:12pt\"><span style=\"color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%\">Other Income, net </span></div><span style=\"color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%\">We recognize fees earned from sources not considered to be within the normal course of business in other income within the statements of </span>operations and comprehensive loss.",
    "successpaymentstabletabletextblock": "The following table summarizes the amounts of the MSKCC success payments:Multiple of Initial Share Price giving rise to a success payment5 x10 x15 xMSKCC success payments (in millions)$10.0 $10.0 $15.0",
    "scheduleofprepaidexpensesandothercurrentassetstabletabletextblock": "Prepaid expenses and other current assets consisted of the following (in thousands):December 31,2023December 31,2022Prepaid contract manufacturing and clinical costs$3,942 $4,803 Prepaid income taxes— 431 Prepaid insurance993 1,568 Other1,220 1,119 Total$6,155 $7,921",
    "numberofsubsidiaries": 4,
    "cashcashequivalentsandshortterminvestments": 372400000,
    "saleofstocknumberofsharesissuedintransaction": 168635,
    "saleofstockconsiderationreceivedontransaction": 1000000,
    "saleofstockpricepershare": 7.32,
    "saleofstockaggregategrossproceeds": 1200000,
    "numberofoperatingsegments": 1,
    "restrictedcash": 100000,
    "patentcostsgross": 4300000,
    "patentreimbursementsexpense": 1500000,
    "otherincome": 15300000,
    "concentrationriskpercentage1": 0.475,
    "propertyplantandequipmentusefullife": "P3Y",
    "assetsfairvaluedisclosure": 262439000,
    "liabilitiesfairvaluedisclosure": 2939000,
    "cashcashequivalentsandavailableforsaledebtsecuritiesamortizedcost": 262328000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 40295000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 331000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 220000,
    "cashcashequivalentsandavailableforsaledebtsecurities": 262439000,
    "availableforsalesecuritiesdebtsecurities": 40185000,
    "cashandcashequivalentsfairvaluedisclosure": 17876000,
    "availableforsalesecuritiesdebtmaturitiesnextrollingtwelvemonthsamortizedcostbasis": 277665000,
    "availableforsalesecuritiesdebtmaturitiesrollingyeartwothroughfiveamortizedcostbasis": 43577000,
    "availableforsalesecuritiesdebtmaturitiessinglematuritydateamortizedcostbasis": 321242000,
    "fairvaluenetderivativeassetliabilitymeasuredonrecurringbasiswithunobservableinputs": 2939000,
    "fairvaluenetderivativeassetliabilitymeasuredonrecurringbasisunobservableinputsreconciliationperiodincreasedecrease": 1288000,
    "successpaymentliabilitymeasurementinput": 5.73,
    "successpaymentliabilityexpectedterm": "P3Y8M12D",
    "fairmarketvaluecommonstockpersharevaluethreshold": 5.1914,
    "clinicalmilestonepayment": 3400000,
    "percentageofsublicensingrevenuessignificantagreements": 0.5,
    "numberofsublicensingagreements": 25,
    "sublicensingexpenses": 1600000,
    "patentprosecutionandmaintenancecosts": 2300000,
    "reductionofgeneralandadministrativeexpenses": 1100000,
    "shareprice": 5.1914,
    "aggregatesuccesspayment": 35000000,
    "maximumlimitedvalueofsuccesspaymentsandcontrolpayment": 35000000,
    "fairvalueofsuccesspaymentsliability": 2900000,
    "contractwithcustomerliabilityrevenuerecognized": 20800000,
    "successpayment": 10000000,
    "revenueremainingperformanceobligation": 8900000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "P12M",
    "accountsreceivableadditions": 10819000,
    "accountsreceivabledeductions": 10873000,
    "contractwithcustomerassetsadditions": 6006000,
    "contractwithcustomerassetsdeductions": 6828000,
    "contractwithcustomerliability": 8949000,
    "contractwithcustomerliabilityadditions": 12981000,
    "contractwithcustomerliabilitydeductions": 29923000,
    "patentcostreimbursements": 1403000,
    "marketablesecurities": 702000,
    "otherreceivablesnetcurrent": 181000,
    "prepaidcontractmanufacturingandclinicalcosts": 3942000,
    "prepaidinsurance": 993000,
    "otherprepaidexpensecurrent": 1220000,
    "propertyplantandequipmentgross": 15581000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 9144000,
    "accumulateddepreciationdepletionandamortizationreclassificationsfrompropertyplantandequipment1": 3500000,
    "employeerelatedliabilitiescurrent": 9517000,
    "accruedresearchanddevelopmentexpenses": 8720000,
    "accruedpatentexpensescurrent": 613000,
    "accruedsublicensingfees": 802000,
    "linesofcreditcurrent": 377000,
    "otherliabilitiescurrent": 1106000,
    "accruedliabilitiesandotherliabilities": 21135000,
    "operatingleaseexpense": 1800000,
    "operatingleaseweightedaverageremainingleaseterm1": "P7Y4M24D",
    "operatingleasecost": 7628000,
    "shorttermleasecost": 250000,
    "leasecost": 7878000,
    "variableleasecost": 2500000,
    "operatingleasepayments": 3732000,
    "operatingleaseweightedaveragediscountratepercent": 0.113,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 3485000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 4475000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 5720000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 5922000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 6122000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 15993000,
    "lesseeoperatingleaseliabilitypaymentsdue": 41717000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 14609000,
    "operatingleaseliability": 27108000,
    "lesseeoperatingleaseoffsettoliabilityrelatedtoincentivestobepaidyeartwo": 1000000,
    "commonstockcapitalsharesreservedforfutureissuance": 9410404,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 3524616,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 3.88,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 25800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y0M0D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 75000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 800000,
    "accruedliabilitiescurrentandnoncurrent": 500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 9410404,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 619022,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4440139,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 9410404,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.03,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.7,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 3.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 7.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 8.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 6432000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 4547000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 6432000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.741,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.035,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 205357,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 78596,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 47193,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 8.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 10.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 10.37,
    "allocatedsharebasedcompensationexpense": 5809000,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.04,
    "definedcontributionplanemployerdiscretionarycontributionamount": 1100000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -101900000,
    "deferredtaxassetsvaluationallowance": 96166000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 103800000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 172700000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 14200000,
    "capitalizedresearchanddevelopmentexpense": 102600000,
    "researchanddevelopmentexpenseamortizationperiod": "P5Y",
    "netoperatinglosscarryforwardsstockownershippercentage": 0.05,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.06,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.24,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": 0.01,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.04,
    "currentstateandlocaltaxexpensebenefit": 15000,
    "currentincometaxexpensebenefit": 15000,
    "deferredfederalincometaxexpensebenefit": 1000,
    "deferredstateandlocalincometaxexpensebenefit": 177000,
    "deferredincometaxexpensebenefit": 178000,
    "deferredtaxassetsoperatinglosscarryforwardsandtaxattributescarryforwards": 51688000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2158000,
    "deferredtaxassetstaxdeferredexpenseother": 697000,
    "deferredtaxassetsstatetaxes": 7000,
    "deferredtaxassetstaxdeferredcapitalizedlicenseandpatentcosts": 1456000,
    "deferredtaxassetsinprocessresearchanddevelopment": 37196000,
    "deferredtaxassetsleasedliabilities": 7098000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4625000,
    "deferredtaxassetsgross": 104925000,
    "deferredtaxassetsnet": 8759000,
    "deferredtaxliabilitiesinvestmentinnoncontrolledaffiliates": 1948000,
    "deferredtaxliabilitiesleasingarrangements": 5808000,
    "deferredtaxliabilitiespropertyplantandequipment": 1560000,
    "deferredincometaxliabilities": 9316000,
    "deferredtaxliabilities": 557000,
    "unrecognizedtaxbenefits": 4093000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1269000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 123000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 98000,
    "valuationallowancedeferredtaxassetchangeinamount": 29758000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 9410404
  },
  {
    "date": "2022-12-30",
    "symbol": "CRBU",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "December 31, 2022",
    "currentfiscalyearenddate": "December 31",
    "documenttransitionreport": "o",
    "entityfilenumber": "001-40631",
    "entityregistrantname": "Caribou Biosciences, Inc.",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "45-3728228",
    "entityaddressaddressline1": "2929 7th Street",
    "entityaddressaddressline2": "Suite 105",
    "entityaddresscityortown": "Berkeley",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 94710,
    "cityareacode": 510,
    "localphonenumber": "982-6030",
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "CRBU",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "o",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "x",
    "entitycentralindexkey": 1619856,
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorfirmid": 34,
    "auditorlocation": "San Francisco, California",
    "cashandcashequivalentsatcarryingvalue": 26669000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 189325000,
    "accountsreceivablenetcurrent": 202000,
    "contractwithcustomerassetnetcurrent": 2247000,
    "otherreceivables": 2215000,
    "prepaidexpenseandotherassetscurrent": 7921000,
    "assetscurrent": 260248000,
    "equitymethodinvestments": 7500000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 69373000,
    "propertyplantandequipmentnet": 10678000,
    "operatingleaserightofuseasset": 24230000,
    "otherassetsnoncurrent": 1538000,
    "assets": 373765000,
    "accountspayablecurrent": 1146000,
    "accruedliabilitiescurrent": 16079000,
    "operatingleaseliabilitycurrent": 966000,
    "contractwithcustomerliabilitycurrent": 9400000,
    "liabilitiescurrent": 28128000,
    "contractwithcustomerliabilitynoncurrent": 13300000,
    "successpaymentliability": 1651000,
    "operatingleaseliabilitynoncurrent": 26780000,
    "deferredincometaxliabilitiesnet": 381000,
    "liabilities": 72894000,
    "commonstockvalue": 6000,
    "additionalpaidincapital": 499598000,
    "accumulatedothercomprehensiveincomelossnetoftax": -1518000,
    "retainedearningsaccumulateddeficit": -197215000,
    "stockholdersequity": -197215000,
    "liabilitiesandstockholdersequity": 373765000,
    "relatedpartycontractwithcustomerliabilitycurrent": 150000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 61029184,
    "commonstocksharesoutstanding": 61029184,
    "revenuefromcontractwithcustomerexcludingassessedtax": 548000,
    "researchanddevelopmentexpense": 82230000,
    "generalandadministrativeexpense": 38020000,
    "operatingexpenses": 120250000,
    "operatingincomeloss": -106399000,
    "equitysecuritiesfvnigainloss": -133000,
    "changeinfairvalueofsuccesspaymentsliability": -2429000,
    "othernonoperatingincome": 4752000,
    "nonoperatingincomeexpense": 7048000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -99351000,
    "incometaxexpensebenefit": 70000,
    "netincomeloss": -99421000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -1383000,
    "comprehensiveincomenetoftax": -100804000,
    "earningspersharebasic": -1.64,
    "earningspersharediluted": -1.64,
    "weightedaveragenumberofsharesoutstandingbasic": 60801133,
    "weightedaveragenumberofdilutedsharesoutstanding": 60801133,
    "sharesoutstanding": 61029184,
    "stockissuedduringperiodsharesstockoptionsexercised": 696913,
    "stockissuedduringperiodvaluestockoptionsexercised": 1497000,
    "stockissuedduringperiodsharesemployeebenefitplan": 69113,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 638000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 11715000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -1383000,
    "profitloss": -99421000,
    "depreciationdepletionandamortization": 1622000,
    "noncashconsiderationforlicensingandcollaborationrevenue": 205000,
    "sharebasedcompensation": 11716000,
    "researchanddevelopmentexpensesoftwareexcludingacquiredinprocesscost": 600000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 797000,
    "noncashleaseexpense": 2019000,
    "increasedecreaseinaccountsreceivable": -951000,
    "increasedecreaseincontractwithcustomerasset": 759000,
    "increasedecreaseinotherreceivables": -3268000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 975000,
    "increasedecreaseinotheroperatingassets": 564000,
    "increasedecreaseinaccountspayable": -2721000,
    "increasedecreaseinaccruedliabilities": 1953000,
    "increasedecreaseincontractwithcustomerliability": -4844000,
    "increasedecreaseinoperatingleaseliability": -403000,
    "increasedecreaseinotheroperatingliabilities": -15000,
    "increasedecreaseindeferredliabilities": -95000,
    "netcashprovidedbyusedinoperatingactivities": -90966000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 252868000,
    "paymentstoacquiremarketablesecurities": 339063000,
    "paymentstoacquirepropertyplantandequipment": 6454000,
    "paymentstoacquireinprocessresearchanddevelopment": 600000,
    "netcashprovidedbyusedininvestingactivities": -93249000,
    "proceedsfromexerciseofstockoptionsandpurchasesofcommonstockunderemployeestockpurchaseplan": 2133000,
    "netcashprovidedbyusedinfinancingactivities": 2133000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -182082000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 58384000,
    "restrictedcashandcashequivalentsatcarryingvalue": 46000,
    "capitalexpendituresincurredbutnotyetpaid": 1223000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 26249000,
    "numberofsubsidiaries": 4,
    "shareprice": 5.1914,
    "cashcashequivalentsandshortterminvestments": 317000000,
    "numberofoperatingsegments": 1,
    "restrictedcash": 100000,
    "patentcostsgross": 7300000,
    "patentreimbursementsexpense": 3500000,
    "otherincome": 4600000,
    "concentrationriskpercentage1": 0.604,
    "propertyplantandequipmentusefullife": 5,
    "assetsfairvaluedisclosure": 197377000,
    "liabilitiesfairvaluedisclosure": 1651000,
    "cashequivalentsatcarryingvalue": 26669000,
    "cashcashequivalentsandavailableforsaledebtsecuritiesamortizedcost": 318555000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 92910000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 32000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 1551000,
    "cashcashequivalentsandavailableforsaledebtsecurities": 317036000,
    "cashandcashequivalentsfairvaluedisclosure": 27693000,
    "availableforsalesecuritiesdebtsecurities": 91966000,
    "fairvaluenetderivativeassetliabilitymeasuredonrecurringbasiswithunobservableinputs": 1651000,
    "fairvaluenetderivativeassetliabilitymeasuredonrecurringbasisunobservableinputsreconciliationperiodincreasedecrease": 2400000,
    "successpaymentliabilitymeasurementinput": 0.106,
    "successpaymentliabilityexpectedterm": 6,
    "clinicalmilestonepayment": 3400000,
    "percentageofsublicensingrevenuessignificantagreements": 0.5,
    "numberofsublicensingagreements": 25,
    "sublicensingexpenses": 100000,
    "patentprosecutionandmaintenancecosts": 5400000,
    "reductionofgeneralandadministrativeexpenses": 2700000,
    "aggregatesuccesspayment": 35000000,
    "maximumlimitedvalueofsuccesspaymentsandcontrolpayment": 35000000,
    "fairvalueofsuccesspaymentsliability": 1700000,
    "increasedecreaseinfairvalueofsuccesspaymentsliability": 2400000,
    "relatedpartytransactionsellinggeneralandadministrativeexpensesfromtransactionswithrelatedparty": 800000,
    "revenues": 900000,
    "upfrontcashpayment": 30000000,
    "successpayment": 15000000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 8000000,
    "contractwithcustomerliabilityrevenuerecognized": 5000000,
    "revenueremainingperformanceobligation": 9900000,
    "accountsreceivableadditions": 8054000,
    "accountsreceivabledeductions": 9005000,
    "contractwithcustomerassetsadditions": 7733000,
    "contractwithcustomerassetsdeductions": 6974000,
    "contractwithcustomerliability": 25891000,
    "contractwithcustomerliabilityadditions": 4432000,
    "contractwithcustomerliabilitydeductions": 9276000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": 12,
    "patentcostreimbursements": 1638000,
    "marketablesecurities": 570000,
    "otherreceivablesnetcurrent": 7000,
    "prepaidcontractmanufacturingandclinicalcosts": 4803000,
    "prepaidtaxes": 431000,
    "prepaidinsurance": 1568000,
    "otherprepaidexpensecurrent": 1119000,
    "propertyplantandequipmentgross": 16327000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 5649000,
    "accumulateddepreciationdepletionandamortizationreclassificationsfrompropertyplantandequipment1": 1600000,
    "employeerelatedliabilitiescurrent": 5752000,
    "accruedresearchanddevelopmentexpenses": 6731000,
    "accruedpatentexpensescurrent": 1331000,
    "accruedsublicensingfees": 596000,
    "linesofcreditcurrent": 299000,
    "otherliabilitiescurrent": 1212000,
    "accruedliabilitiesandotherliabilities": 15921000,
    "operatingleaseexpense": 1800000,
    "operatingleaseweightedaverageremainingleaseterm1": 8.3,
    "operatingleaseweightedaveragediscountratepercent": 0.113,
    "operatingleasecost": 7337000,
    "shorttermleasecost": 83000,
    "leasecost": 7420000,
    "variableleasecost": 2200000,
    "operatingleasepayments": 3468000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 3333000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 3883000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 4475000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 5720000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 5922000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 22116000,
    "lesseeoperatingleaseliabilitypaymentsdue": 45449000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 17703000,
    "operatingleaseliability": 27746000,
    "lesseeoperatingleaseoffsettoliabilityrelatedtoincentivestobepaidyearone": 1100000,
    "lesseeoperatingleaseoffsettoliabilityrelatedtoincentivestobepaidyeartwo": 600000,
    "commonstockcapitalsharesreservedforfutureissuance": 5833979,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1409475,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 5.82,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 26500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.1,
    "accruedliabilitiescurrentandnoncurrent": 300000,
    "allocatedsharebasedcompensationexpense": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6733074,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 737079,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 2621576,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 6733074,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.01,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 8.81,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.14,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 9.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 8.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 8203000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 5256000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 8203000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.742,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.044000000000000004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 256146,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 259839,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 3693,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 10.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 10.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 9.9,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 600000,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.04,
    "definedcontributionplanemployerdiscretionarycontributionamount": 700000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -99400000,
    "deferredtaxassetsvaluationallowance": 66408000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 74800000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 125500000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 4900000,
    "deferredtaxassetsincreasedecreaseduetocapitalizationnetofamortization": 84900000,
    "netoperatinglosscarryforwardsstockownershippercentage": 0.05,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.08,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.08,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.03,
    "effectiveincometaxratereconciliationotheradjustments": 0.01,
    "currentfederaltaxexpensebenefit": 163000,
    "currentstateandlocaltaxexpensebenefit": 2000,
    "currentincometaxexpensebenefit": 165000,
    "deferredstateandlocalincometaxexpensebenefit": -95000,
    "deferredincometaxexpensebenefit": -95000,
    "deferredtaxassetsoperatinglosscarryforwardsandtaxattributescarryforwards": 37120000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1539000,
    "deferredtaxassetstaxdeferredexpenseother": 7493000,
    "deferredtaxassetsstatetaxes": 7000,
    "deferredtaxassetstaxdeferredcapitalizedlicenseandpatentcosts": 1311000,
    "deferredtaxassetsinprocessresearchanddevelopment": 18462000,
    "deferredtaxassetsleasedliabilities": 8058000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2921000,
    "deferredtaxassetsgross": 76911000,
    "deferredtaxassetsnet": 10503000,
    "deferredtaxliabilitiesinvestmentinnoncontrolledaffiliates": 1713000,
    "deferredtaxliabilitiesleasingarrangements": 7037000,
    "deferredtaxliabilitiespropertyplantandequipment": 2134000,
    "deferredincometaxliabilities": 10884000,
    "deferredtaxliabilities": 381000,
    "unrecognizedtaxbenefits": 2799000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 847000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 250000,
    "valuationallowancedeferredtaxassetchangeinamount": 31887000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7038329
  },
  {
    "date": "2021-12-30",
    "symbol": "CRBU",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Caribou Biosciences, Inc.",
    "entitycentralindexkey": 1619856,
    "entityfilenumber": "001-40631",
    "entitytaxidentificationnumber": "45-3728228",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "true",
    "entityfilercategory": "Non-accelerated filer",
    "entityinteractivedatacurrent": "Yes",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityaddressaddressline1": "2929 7th Street",
    "entityaddressaddressline2": "Suite 105",
    "entityaddresscityortown": "Berkeley",
    "entityaddressstateorprovince": "California",
    "entityincorporationstatecountrycode": "Delaware",
    "entityaddresspostalzipcode": 94710,
    "localphonenumber": "982-6030",
    "cityareacode": 510,
    "security12btitle": "Common Stock, par value $0.0001 per share",
    "tradingsymbol": "CRBU",
    "securityexchangename": "The Nasdaq Global Select Market",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "icfrauditorattestationflag": "false",
    "auditorname": "Deloitte & Touche LLP",
    "auditorlocation": "San Francisco, California",
    "auditorfirmid": 34,
    "cashandcashequivalentsatcarryingvalue": 240420000,
    "marketablesecuritiescurrent": 135412000,
    "accountsreceivablenetcurrent": 1153000,
    "capitalizedcontractcostnetcurrent": 1488000,
    "otherreceivables": 5483000,
    "prepaidexpenseandotherassetscurrent": 7236000,
    "assetscurrent": 391192000,
    "equitymethodinvestments": 7500000,
    "marketablesecuritiesnoncurrent": 37676000,
    "propertyplantandequipmentnet": 4887000,
    "otherassetsnoncurrent": 975000,
    "assets": 442356000,
    "accountspayablecurrent": 3990000,
    "accruedliabilitiescurrent": 13136000,
    "deferredrevenue": 8703000,
    "liabilitiescurrent": 25829000,
    "deferredrevenuenoncurrent": 19100000,
    "deferredrentcreditnoncurrent": 2097000,
    "successpaymentliability": 4080000,
    "otherliabilities": 17000,
    "deferredincometaxliabilitiesnet": 476000,
    "liabilities": 54531000,
    "commonstockvalue": 6000,
    "additionalpaidincapital": 485748000,
    "accumulatedothercomprehensiveincomelossnetoftax": -135000,
    "retainedearningsaccumulateddeficit": -97794000,
    "stockholdersequity": -97794000,
    "liabilitiesandstockholdersequity": 442356000,
    "deferredrevenuecurrent": 8300000.000000001,
    "temporaryequityparorstatedvaluepershare": 0.0001,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": "null",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "revenuefromcontractwithcustomerexcludingassessedtax": 685000,
    "researchanddevelopmentexpense": 52255000,
    "generalandadministrativeexpense": 24322000,
    "operatingexpenses": 76577000,
    "operatingincomeloss": -66979000,
    "interestincomeother": 148000,
    "interestexpense": 8000,
    "changeinfairvalueofsuccesspaymentsliability": 1426000,
    "gainslossesonextinguishmentofdebt": 1584000,
    "othernonoperatingincome": 79000,
    "nonoperatingincomeexpense": 377000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -66602000,
    "incometaxexpensebenefit": 321000,
    "netincomeloss": -66923000,
    "marketablesecuritiesunrealizedgainloss": -135000,
    "comprehensiveincomenetoftax": -67058000,
    "earningspersharebasicanddiluted": -2.11,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesoutstanding": "null",
    "temporaryequitystockissuedduringperiodvaluenewissues": 108827000,
    "temporaryequitystockissuedduringperiodsharesnewissues": "null",
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 150150000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": "null",
    "stockissuedduringperiodvaluenewissues": 321020000,
    "stockissuedduringperiodsharesnewissues": "null",
    "repaymentofloanissuedbystockholder": 1150000,
    "stockissuedduringperiodvaluestockoptionsexercised": 2551000,
    "stockissuedduringperiodsharesstockoptionsexercised": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3449000,
    "othercomprehensiveincomelossavailableforsalesecuritiesadjustmentnetoftax": -135000,
    "profitloss": -66923000,
    "paymentsofstockissuancecosts": 28600000,
    "depreciationdepletionandamortization": 984000,
    "gainlossondispositionofassets1": -4000,
    "sharebasedcompensation": 3449000,
    "researchanddevelopmentexpensesoftwareexcludingacquiredinprocesscost": 1000000,
    "extinguishmentofdebtgainlossnetoftax": 1578000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 52000,
    "increasedecreaseinaccountsreceivable": 1003000,
    "increasedecreaseincontractwithcustomerasset": 200000,
    "increasedecreaseinotherreceivables": 1800000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 4043000,
    "increasedecreaseinotheroperatingassets": 316000,
    "increasedecreaseinaccountspayable": 1139000,
    "increasedecreaseinaccruedliabilities": 4281000,
    "increasedecreaseindeferredrevenue": 29637000,
    "increasedecreaseindeferredrentandleaseincentiveliability": 1173000,
    "increasedecreaseinotheroperatingliabilities": -162000,
    "increasedecreaseindeferredliabilities": 321000,
    "netcashprovidedbyusedinoperatingactivities": -32519000,
    "paymentstoacquirepropertyplantandequipment": 2121000,
    "paymentstoacquireinprocessresearchanddevelopment": 1000000,
    "paymentstoacquiremarketablesecurities": 173276000,
    "netcashprovidedbyusedininvestingactivities": -176397000,
    "proceedsfromissuanceinitialpublicoffering": 321020000,
    "proceedsfromissuanceofconvertiblepreferredstock": 108827000,
    "proceedsfromstockoptionsexercised": 2551000,
    "proceedsfromrepaymentsofnotespayable": 1150000,
    "repaymentsoflongtermcapitalleaseobligations": 119000,
    "netcashprovidedbyusedinfinancingactivities": 433429000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 224513000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 240466000,
    "restrictedcashandcashequivalentsatcarryingvalue": 46000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 240466000,
    "incometaxespaidnet": 11000,
    "capitalexpendituresincurredbutnotyetpaid": 265000,
    "extinguishmentofdebtamountandaccruedinterest": 1578000,
    "conversionofconvertiblepreferredstocktocommonstockatclosingofinitialpublicoffering": 150150000,
    "shareprice": 5.1914,
    "cashcashequivalentsandshortterminvestments": 413500000,
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": 10,
    "lessoroperatingleasedescription": "Lease agreements that contain a bargain purchase option, a full transfer of ownership at the completion of the lease term, a lease term that is at least 75% of the useful lives of the assets, or present value of payments in excess of 90% of fair market value of the leased asset are accounted for as capital leases.",
    "restrictedcash": 100000,
    "patentcostsgross": 12300000,
    "patentreimbursementsexpense": 7100000,
    "otherincome": 100000,
    "concentrationriskpercentage1": 0.6970000000000001,
    "assetsfairvaluedisclosure": 205390000,
    "liabilitiesfairvaluedisclosure": 4080000,
    "cashequivalentsatcarryingvalue": 58892000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 413643000,
    "availableforsalesecuritiesunrealizedgain": 6000,
    "availableforsalesecuritiesunrealizedloss": -141000,
    "availableforsalesecuritiesestimatedfairvalue": 37676000,
    "fairvaluenetderivativeassetliabilitymeasuredonrecurringbasiswithunobservableinputs": 4080000,
    "fairvaluenetderivativeassetliabilitymeasuredonrecurringbasisunobservableinputsreconciliationperiodincreasedecrease": 1400000,
    "alternativeinvestment": 15090,
    "alternativeinvestmentmeasurementinput": 0.209,
    "successpaymentliabilityassumptionsterm": 5.5,
    "clinicalmilestonepayment": 3400000,
    "sublicensingexpenses": 800000,
    "reductionofgeneralandadministrativeexpenses": 5200000,
    "aggregatesuccesspayment": 35000000,
    "maximumlimitedvalueofsuccesspaymentsandcontrolpayment": 35000000,
    "fairvalueofsuccesspaymentsliability": 4099999.9999999995,
    "increasedecreaseinfairvalueofsuccesspaymentsliability": 1400000,
    "relatedpartytransactionsellinggeneralandadministrativeexpensesfromtransactionswithrelatedparty": 1900000,
    "researchcollaborationagreementperiod": "four-year",
    "patentprosecutionandmaintenancecosts": 10500000,
    "revenues": 200000,
    "upfrontcashpayment": 30000000,
    "reimbursementexpense": 200000,
    "sharesissuedpricepershare": 15,
    "successpayment": 15000000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 4000000,
    "contractwithcustomerassetincreasedecreaseforcontractacquiredinbusinesscombination": 200000,
    "decreaseinregulatorymilestone": 300,
    "deferredrevenuerevenuerecognized1": 30000000,
    "contractwithcustomerliabilityrevenuerecognized": 100000,
    "revenueremainingperformanceobligation": 8700000,
    "accountsreceivableadditions": 9105000,
    "accountsreceivabledeductions": 8102000,
    "contractwithcustomerassetnetcurrent": 1488000,
    "contractwithcustomerassetsadditions": 5144000,
    "contractwithcustomerassetsdeductions": 4984000,
    "contractwithcustomerliability": 30735000,
    "contractwithcustomerliabilityadditions": 35022000,
    "contractwithcustomerliabilitydeductions": 5385000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "12 months",
    "patentcostreimbursements": 4702000,
    "marketablesecurities": 226000,
    "otherreceivablesnetcurrent": 555000,
    "prepaidtaxes": 2714000,
    "prepaidinsurance": 1897000,
    "prepaidcontractmanufacturingandclinicalcosts": 1486000,
    "prepaidrent": 468000,
    "otherprepaidexpensecurrent": 671000,
    "propertyplantandequipmentgross": 8964000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 4077000,
    "accumulateddepreciationdepletionandamortizationreclassificationsfrompropertyplantandequipment1": 1000,
    "employeerelatedliabilitiescurrent": 4225000,
    "accruedresearchanddevelopmentexpenses": 4065000,
    "accruedpatentexpensescurrent": 3213000,
    "accruedsublicensingfees": 586000,
    "linesofcreditcurrent": 259000,
    "otherliabilitiescurrent": 788000,
    "accruedliabilitiesandotherliabilities": 13136000,
    "variableinterestentityownershippercentage": 0.05,
    "relatedpartytransactionexpensesfromtransactionswithrelatedparty": 100000,
    "lesseeoperatingleaseoptiontoextend": "lease laboratory and office space under non-cancellable operating agreements. On March 31, 2021, we entered into a ten-year lease agreement, which superseded and replaced our prior lease, as amended, and the lease included additional office and laboratory space located within the same building in Berkeley, California. Our lease agreement contains a renewal option for an additional term of five years",
    "operatingleasepayments": 3500000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 38300000,
    "securitydeposit": 800000,
    "operatingleaseexpense": 4000000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 3596000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 3708000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 3627000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 4838000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfourandthereafter": 22541000,
    "lesseeoperatingleaseliabilitypaymentsdue": 41795000,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "10 years",
    "commonstockoutstandingpercentage": 0.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 7.39,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 34500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3.1,
    "allocatedsharebasedcompensationexpense": 100000,
    "accruedliabilitiescurrentandnoncurrent": 300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantadditionofnewsharesinperiod": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantreductionduetooptionsgrantedinperiod": "-null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrantadditionduetooptionsforfeituresandcancelledinperiod": 155908,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 155908,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 8.57,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.99,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 2.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 2.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 8.57,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageremainingcontractualterm": 9.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 5.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 8.7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 50085000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 16519000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 50085000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.765,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.016,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 0.04,
    "definedcontributionplanemployerdiscretionarycontributionamount": 400000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -66599999.99999999,
    "unrecognizedtaxbenefits": 2202000,
    "deferredtaxassetsvaluationallowance": 34521000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 87700000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 74200000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 4200000,
    "percentageofcoronavirusaidreliefandeconomicsecurityactremoveslimitfortaxableyears": 1,
    "netoperatinglosscarryforwardsstockownershippercentage": 0.05,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.09,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.09,
    "effectiveincometaxratereconciliationsharebasedcompensationexcesstaxbenefitpercent": -0.01,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.04,
    "currentstateandlocaltaxexpensebenefit": 1000,
    "currentincometaxexpensebenefit": 1000,
    "deferredfederalincometaxexpensebenefit": 317000,
    "deferredstateandlocalincometaxexpensebenefit": 3000,
    "deferredincometaxexpensebenefit": 320000,
    "deferredtaxassetsoperatinglosscarryforwardsandtaxattributescarryforwards": 32878000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1055000,
    "deferredtaxassetstaxdeferredexpenseother": 872000,
    "deferredtaxassetsstatetaxes": 7000,
    "deferredtaxassetstaxdeferredcapitalizedlicenseandpatentcosts": 1980000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 576000,
    "deferredtaxassetsgross": 37368000,
    "deferredtaxassetsnet": 2847000,
    "deferredtaxliabilitiesinvestmentinnoncontrolledaffiliates": 2077000,
    "deferredtaxliabilitiespropertyplantandequipment": 1246000,
    "deferredincometaxliabilities": 3323000,
    "deferredtaxassetsliabilitiesnet": 476000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 869000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 7000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 27000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null"
  }
]